Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy
Brain Tumor Pathology · 2024-04 · 41 (2) · 43-49
DOI: 10.1007/s10014-024-00480-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Tumor Pathology, online erschienen am 02.04.2024. Verfasst von Hikaru Sasaki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa, Chiba, 272-8523, Japan. hssasaki@tdc.ac.jp. Hauptthemen laut MEDLINE: Oligodendroglioma, Isocitrate Dehydrogenase, Brain Neoplasms, Chromosomes, Human, Pair 1. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Eisai.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa, Chiba, 272-8523, Japan. hssasaki@tdc.ac.jp.
- Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. hssasaki@tdc.ac.jp.
- Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
- Department of Neurosurgery, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, 470-1192, Japan.
Förderung
- Japan Society for the Promotion of Science
- Eisai
Zitieren
APA
Sasaki, H., Kitamura, Y., Toda, M., Hirose, Y., & Yoshida, K. (2024). Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain Tumor Pathology, 41(2), 43-49. https://doi.org/10.1007/s10014-024-00480-1
Vancouver
Sasaki H, Kitamura Y, Toda M, Hirose Y, Yoshida K. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain Tumor Pathology. 2024;41(2):43-49. doi:10.1007/s10014-024-00480-1
BibTeX
@article{Sasaki2024,
author = {Sasaki, Hikaru and Kitamura, Yohei and Toda, Masahiro and Hirose, Yuichi and Yoshida, Kazunari},
title = {Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy},
journal = {Brain Tumor Pathology},
year = {2024},
volume = {41},
number = {2},
pages = {43--49},
doi = {10.1007/s10014-024-00480-1}
}
EUVIMED